X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
abridged index medicus (1) 1
adult (1) 1
aged (1) 1
antigens (1) 1
antitumor activity (1) 1
b-cell (1) 1
b-cell maturation antigen - antagonists & inhibitors (1) 1
blood (1) 1
cancer (1) 1
care and treatment (1) 1
cd4-cd8 ratio (1) 1
cytokines (1) 1
drug dosages (1) 1
female (1) 1
humans (1) 1
immunomodulation (1) 1
immunotherapy (1) 1
immunotherapy, adoptive - adverse effects (1) 1
index medicus (1) 1
infusions, intravenous (1) 1
kte-c19 (1) 1
leukopenia (1) 1
lymphocytes (1) 1
lymphocytes b (1) 1
lymphocytes t (1) 1
male (1) 1
management (1) 1
maturation antigen (1) 1
medicine, general & internal (1) 1
middle aged (1) 1
minimal residual disease (1) 1
multicenter (1) 1
multiple myeloma (1) 1
multiple myeloma - immunology (1) 1
multiple myeloma - therapy (1) 1
neutropenia (1) 1
patients (1) 1
progression-free survival (1) 1
proteasome inhibitors (1) 1
receptors, chimeric antigen - therapeutic use (1) 1
remissions (1) 1
selinexor (1) 1
studies (1) 1
t-lymphocytes - metabolism (1) 1
thrombocytopenia (1) 1
toxicity (1) 1
usage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2019, Volume 380, Issue 18, pp. 1726 - 1737
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 488 - 488
Abstract Introduction: Immunomodulatory chimeric antigen receptor (CAR) T cell therapy directed against B-cell maturation antigen (BCMA) has shown promising... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.